Cytokinetics, Inc. Share Price Nasdaq
Stocks
US23282W1009
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 06-29 | Cytokinetics Insider Sold Shares Worth $266,390, According to a Recent SEC Filing | MT |
| 06-29 | Cytokinetics Seen Gaining From Myqorzo Momentum to Treat Heart Conditions, UBS Says | MT |
| Market Cap | 11.85B 10.37B 9.58B 8.94B 16.83B 1,120B 17.22B 115B 44.49B 553B 44.49B 43.52B 1,919B | P/E 2026 * |
-13.5x | P/E 2027 * | -18.8x |
|---|---|---|---|---|---|
| Enterprise Value | 11.26B 9.86B 9.1B 8.5B 16.01B 1,065B 16.37B 110B 42.3B 525B 42.3B 41.37B 1,824B | EV / Sales 2026 * |
104x | EV / Sales 2027 * | 28.6x |
| Free-Float |
98.21% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Cytokinetics, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Blum
CEO | Chief Executive Officer | 62 | 31/12/2006 |
Sung Lee
DFI | Director of Finance/CFO | 55 | 07/05/2024 |
| Chief Administrative Officer | 57 | 13/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Blum
BRD | Director/Board Member | 62 | 31/12/2006 |
John Henderson
CHM | Chairman | 81 | 07/04/2022 |
Wendell Wierenga
BRD | Director/Board Member | 78 | 08/02/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.13% | -1.33% | +63.86% | +121.93% | 55.78B | |
| +6.76% | +18.10% | +91.66% | +104.09% | 55.66B | |
| +3.33% | +4.51% | -11.68% | -11.91% | 23.84B | |
| +1.32% | +6.22% | +5.28% | +415.45% | 22.7B | |
| +0.97% | +3.81% | +31.23% | -32.21% | 16.12B | |
| -0.89% | +5.71% | +24.30% | +186.29% | 13.64B | |
| +9.96% | +15.98% | +157.65% | +310.89% | 14.8B | |
| +2.85% | +2.81% | +75.32% | +139.44% | 12.16B | |
| +2.04% | -1.83% | +400.62% | +124.05% | 11.34B | |
| Average | +2.94% | +6.06% | +93.14% | +150.89% | 25.12B | |
| Weighted average by Cap. | +3.10% | +7.09% | +75.79% | +139.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 109M 95.24M 87.92M 82.1M 155M 10.28B 158M 1.06B 408M 5.07B 408M 400M 17.61B | 393M 344M 318M 297M 559M 37.16B 571M 3.82B 1.48B 18.33B 1.48B 1.44B 63.65B |
| Net income | -805M -705M -651M -608M -1.14B -76.09B -1.17B -7.83B -3.02B -37.54B -3.02B -2.96B -130B | -653M -572M -528M -493M -928M -61.75B -949M -6.35B -2.45B -30.46B -2.45B -2.4B -106B |
| Net Debt | -583M -511M -472M -440M -829M -55.16B -848M -5.68B -2.19B -27.21B -2.19B -2.14B -94.48B | -601M -526M -485M -453M -853M -56.78B -873M -5.84B -2.26B -28.01B -2.26B -2.21B -97.25B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
